BSE filing, NSE: BALGOPAL. Summary written from the filing by ALFA Finder's alert engine.
Balgopal Commercial Ltd: key numbers
- Share price
- ₹147.10
- Market cap
- ₹279.6 Cr
- Revenue (annual)
- ₹0.02 Cr
- Net profit (annual)
- ₹-8.85 Cr
- P/E (TTM)
- -52.1×Sector 45.0×
- Promoter holding
- 55.38%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balgopal Commercial Ltd
All →Balgopal Commercial Other Announcement
Balgopal Commercial Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI Regulation 31(1)(b).
Balgopal Commercial ED Probe / Tax Survey
Balgopal Commercial Limited confirms that the Income Tax Department has concluded its search at company premises. No communication on potential financial impact has been received yet.
Balgopal Commercial Annual General Meeting
Balgopal Commercial Limited filed the Scrutinizer's Report and voting results for its 44th Annual General Meeting held on September 30, 2026.
Balgopal Commercial ED Probe / Tax Survey
Balgopal Commercial Limited reported an ongoing visit by Income Tax Department officials at its premises. Directors and senior management are currently attending to the proceedings with restricted communication.
Balgopal Commercial Board Meeting Outcome
Balgopal Commercial Limited approved a corrigendum to its AGM notice regarding a proposed name change to Dreamax Enterprises Limited. This update follows observations from BSE regarding the company's application.
Balgopal Commercial Annual General Meeting
Balgopal Commercial Limited issued a corrigendum to its AGM notice regarding a proposed name change to Dreamax Enterprises Limited. The update includes a revised Chartered Accountant's certificate.
Other adverse business impact announcements
All →Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.